PRINCETON, NJ--(MARKET WIRE)--Aug 27, 2007 -- Barrier Therapeutics, Inc. (NasdaqGM:BTRX - News), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, and Mr. Al Altomari, Chief Operating Officer, will present an overview of the Company’s business activities and product pipeline at select investor conferences during the month of September.
